April 2022 Seminar on PrEP Financing and Logistics
April 28, 2022
Topic: Clinical Tools and Guidelines
Opt-Out ED Screening for HIV, HCV, and Syphilis—Dear Colleague Letter from CDPH
March 28, 2022: Emergency departments (EDs) are uniquely positioned to identify people with syphilis, HIV, and hepatitis C who otherwise might remain undiagnosed. The California Department of Public Health (CDPH) recommends that EDs consider implementing routine opt-out testing for syphilis, HIV, and hepatitis C.
Identification and immediate treatment through the ED may have the added benefit of furthering health equity for those disproportionately affected by these infections
2021 CDC STI Treatment Guidelines Update: What’s New
December 10, 2021
Presented by Drs. Sharon Adler and Kelly Johnson
Learn more about the 2021 CDC STI Treatment Guidelines. Updated every 4-5 years, CDC’s STI Treatment Guidelines provide current evidence-based diagnostic, management, and treatment recommendations, and serve as a source of clinical guidance for managing sexually transmitted infections (STIs). This webinar will cover 2021 changes.
Learning Objectives
- Learn about and become proficient with the treatment updates
- Discuss and be able to share the rationale for the updates
- Understand the changes needed and apply them to clinical practice
2021 PrEP Clinical Practice Guideline – Clinical Providers’ Supplement
Updated Clinical Providers’ Supplement accompanying the 2021 PrEP Clinical Practice Guideline.
Updates for 2021 include:
- Checklist updated to include Descovy, 2-1-1 Truvada for MSM, and cabotegravir
- Added PrEP with intramuscular cabotegravir (CAB) injections (conditional on FDA approval) recommendation for HIV prevention in adults
- Added information about Descovy and cabotegravir to Patient Information Sheets
2021 PrEP Clinical Practice Guideline
Comprehensive information for the use of antiretroviral preexposure prophylaxis (PrEP) to prevent acquiring HIV infection.
Updates for 2021 include:
- A recommendation to inform all sexually active adults and adolescents about PrEP
- PrEP with intramuscular cabotegravir (CAB) injections (conditional on FDA approval) is recommended for HIV prevention in adults reporting sexual behaviors that place them at substantial ongoing risk of HIV exposure and acquisition.
Also view the updated PrEP Providers Supplement for 2021.
Comprehensive information for the use of antiretroviral preexposure prophylaxis (PrEP) to prevent acquiring HIV infection.
Updates for 2021 include:
- A recommendation to inform all sexually active adults and adolescents about PrEP
- PrEP with intramuscular cabotegravir (CAB) injections (conditional on FDA approval) is recommended for HIV prevention in adults reporting sexual behaviors that place them at substantial ongoing risk of HIV exposure and acquisition.
Also view the updated PrEP Providers Supplement for 2021.
California STI Treatment Guidelines Table for Adults and Adolescents—2021
These guidelines reflect the 2021 CDC STI Treatment Guidelines for adults and adolescents who are HIV negative as well as those with HIV.
2021 CDC STI Treatment Guidelines Webinar
2021 CDC STI Treatment Guidelines Webinar presented by National Network of STD Prevention Training Center (NNPTC) faculty Dr. Ina Park, Dr. Rosalyn Plotzker, and Dr. Christine Johnston.
2021 Implementing the CDC STI Treatment Guidelines: A Conversation for Family PACT Providers
The long-awaited 2021 CDC Sexually Transmitted Infections Treatment Guidelines were published in MMWR on July 22, 2021. This webinar will focus on significant changes from the 2015 CDC STD Treatment Guidelines, including updated guidelines for the screening, diagnosis and treatment of gonorrhea, chlamydia, syphilis, pelvic inflammatory disease, genital herpes, Mycoplasma genitalium, and vaginal trichomoniasis. To assist health care providers in obtaining a sexual history, the updated “Five P’s” approach will be reviewed. In addition, current Family PACT benefits for each type of sexually transmitted infection discussed in the program will be explained.
Learning Objectives:
- List 3 examples of sexual history questions for each the “Five P’s” of sexual history taking
- Explain why the treatment guidelines for both chlamydia and gonorrhea genital tract infections were updated in the 2021 Guidelines
- List the indications for obtaining chlamydia and gonorrhea samples from the anus and the oropharynx
- Describe the consequences of Mycoplasma genitalium genital infection in males and females
- List 2 updates in the 2021 Guidelines regarding vaginal trichomoniasis
Presenters:
- Ina Park, MD, MS, Co-author of the CDC STI Treatment Guidelines, 2021
- Michael Policar, MD, MPH
Resources:
2021 STI Treatment Guidelines
Current evidence-based prevention, diagnostic and treatment recommendations that replace the 2015 STI treatment guidance. Although the guidelines emphasize treatment, prevention strategies and diagnostic recommendations also are discussed.
Syphilis Health Check™
Current evidence-based prevention, diagnostic and treatment recommendations that replace the 2015 STI treatment guidance. Although the guidelines emphasize treatment, prevention strategies and diagnostic recommendations also are discussed.